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ABSTRACT
Fluorides are present in the environment. Excessive 
systemic exposure to fluorides can lead to distur-
bances of bone homeostasis (skeletal fluorosis) 
and enamel development (dental/enamel fluoro-
sis). The severity of dental fluorosis is also depen-
dent upon fluoride dose and the timing and 
duration of fluoride exposure. Fluoride’s actions 
on bone cells predominate as anabolic effects both 
in vitro and in vivo. More recently, fluoride has 
been shown to induce osteoclastogenesis in mice. 
Fluorides appear to mediate their actions through 
the MAPK signaling pathway and can lead to 
changes in gene expression, cell stress, and cell 
death. Different strains of inbred mice demonstrate 
differential physiological responses to ingested 
fluoride. Genetic studies in mice are capable of 
identifying and characterizing fluoride-responsive 
genetic variations. Ultimately, this can lead to the 
identification of at-risk human populations who 
are susceptible to the unwanted or potentially 
adverse effects of fluoride action and to the eluci-
dation of fundamental mechanisms by which fluo-
ride affects biomineralization.
KEY WORDS: bone, enamel, fluoride, fluorosis, 
mice.
INTRODuCTION
Fluorine is a common element in the earth’s crust. Fluorides are naturally present in the soil, rocks, and water throughout the world, with higher 
concentrations in areas where there have been recent/past pyroclastic activi-
ties or geologic uplift. Fluorides are also widely used in many industrial pro-
cesses. The major sources of systemic fluoride exposure are the diet (food and 
water) (USDA National Fluoride Database of Selected Beverages and Foods – 
2004, http://www.nal.usda.gov/fnic/foodcomp/Data/Fluoride/Fluoride.html) 
and fluoride-containing dental products.
Fluoridation of community drinking water to prevent dental caries is con-
sidered as one of the ten most important public health achievements of the 
20th century (Achievements in Public Health, 1900-1999: Fluoridation of 
Drinking Water to Prevent Dental Caries, 1999). Concurrent with the decline 
in dental caries has been an increase in the prevalence of dental fluorosis, a 
side-effect of fluoride exposure. Dental fluorosis remains highly prevalent 
world-wide. As recently as 2005, 23% of persons in the United States aged 6 
to 39 years had very mild or greater enamel fluorosis (Beltran-Aguilar et al., 
2005).
Historically, biochemists and protein chemists have used fluoride in mil-
limolar (mM) concentrations as an enzyme inhibitor (e.g., phenylmethylsul-
fonyl fluoride is an inhibitor of a variety of serine proteases, whereas sodium 
fluoride is used as a general inhibitor of protein phosphoseryl and phos-
phothreonyl phosphatases). Efforts to understand additional actions of fluo-
ride in cells, tissues, and organisms have been hampered by the use of a wide 
range of fluoride exposures, different fluoride salts (AlFn, BeFn, or NaF), or 
organic moieties of fluorine. Studies involving humans have focused on fluo-
ride alone or in combination with other molecules (i.e., calcium). Studies 
involving animals vary in fluoride-dosing schedules as well as routes of 
administration (orally or parenterally). Finally, fluoride can demonstrate 
biphasic actions (i.e., mitogenic at low concentrations and toxic at higher 
concentrations). Collectively, this has complicated our understanding of the 
physiological effects of fluoride. Within this decade, the interaction of an 
individual’s genetic background has offered new insight into fluoride’s 
physiological effects. This review will focus on separate but often overlap-
ping areas of fluoride action and genetic influences in modulating an animal’s 
response to fluoride.
CELL SIGNALING, PROLIFERATION, STRESS, AND APOPTOSIS
As alluded to above, fluoride is part of the environment, whether one considers 
systemic exposure in whole animals or as part of the tissue culture milieu. 
Mitogen-activated protein kinases (MAPKs) signaling pathways allow cells to 
respond to myriad extracellular stimuli. The Jun N-terminal kinase (JNK) and 
p38 MAPK pathways are often activated following environmental stress (Weston 
and Davis, 2007; Wagner and Nebreda, 2009). Activation of these pathways can 
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lead to diverse responses, including cell proliferation, differentia-
tion, survival, and apoptosis. Sodium fluoride appears to act pre-
dominantly through the Jun N-terminal kinase (JNK) and p38 
MAPK signaling pathways (Thrane et al., 2001; Y Zhang et al., 
2007; Karube et al., 2009). An alternative MAPK / ERK1 signal-
ing pathway involving an osteoblastic fluoride-sensitive phospho-
tyrosyl phosphatase (PTP) has been proposed in regard to the 
mitogenic effects of fluoride (Thomas et al., 1996; Wu et al., 1997; 
Lau and Baylink, 1998). When fluoride is associated with metals 
like aluminum and beryllium, more complex signaling pathways 
appear to be evoked (Lau et al., 1991, 2002; Caverzasio et al., 
1996, 1997; Susa, 1999; Misra et al., 2002; Li, 2003). Finally, in 
ameloblasts there is evidence that the Rho/ROCK pathway is acti-
vated by modest fluoride exposure (Li et al., 2005).
Fluoride can have deleterious effects on cells, depending 
upon concentration (micromolar to millimolar), duration of 
exposure, and cell type (primary cultured cells or established 
cell lines). Exposures up to 1 mM of NaF failed to induce stress-
response RNAs or initiate apoptosis in the mouse odontoblast 
cell line M06-G3 (Wurtz et al., 2008), whereas 1 mM NaF 
induced oxidative stress and apoptosis in rat primary hippocam-
pal neurons (M Zhang et al., 2007). Exposures in the 5- to 
10-mM range are required to induce apoptosis in rat thymocytes 
and human gingival fibroblasts, rat primary lung cells, and in the 
odontoblast cell line MDPC-23 (Thrane et al., 2001; Matsui
et al., 2007; Lee et al., 2008; Karube et al., 2009), and micro-
molar NaF leads to apoptosis in neonatal rat osteoblasts and 
fetal human ameloblast lineage cells (Q Yan et al., 2007; X Yan 
et al., 2009). Rats exposed to 0, 10, 50, or 100 ppm F ions 
(approximately 0 to 5.0 mM F ions) in the drinking water over 
a period of 10 wks demonstrated increases in reactive oxygen 
species in the blood at 50 ppm and 100 ppm, without evidence 
of significant oxidative stress within the brain or liver (Chouhan 
and Flora, 2008). In the kidney, there was increased oxidative 
stress only in the 100-ppm-F group. Analysis of these data 
together suggests tissue-specific sensitivity to oxidative stress 
following fluoride exposure.
Endoplasmic reticulum (ER) stress may be a component of 
fluoride’s effects on amelogenesis. Depending upon the chemi-
cal form and concentration, fluoride can induce ER stress 
(Thrane et al., 2001; Misra et al., 2002; Kubota et al., 2005; 
Sharma et al., 2008; Ito et al., 2009). ER stress leading to pro-
tein misfolding can result from several insults. To alleviate the 
accumulation of unfolded proteins in the ER lumen, the unfolded 
protein response (UFP) is initiated. Two primary mechanisms 
are in place to deal with the accumulation of unfolded/misfolded 
proteins: increased transcription of genes encoding the protein 
chaperones and folding catalysts to up-regulate the cell’s 
protein-folding capacity; and decreased biosynthetic burden of 
the secretory pathway in the cell by down-regulating expression 
of genes encoding secreted proteins (Rutkowski and Kaufman, 
2004; Shen et al., 2004; Schroder and Kaufman, 2005). The 
reduction of incoming proteins appears to be mediated at the 
level of translation. Additionally, the UFP response leads to 
transcriptional up-regulation for adaptation or for apoptosis 
(Kaufman, 1999; Malhotra and Kaufman, 2007). Within the ER 
stress cascade is the activation of c-Jun amino-terminal kinases 
(JNKs) via mammalian homologs of yeast IRE1, which activate 
chaperone genes in response to ER stress (Urano et al., 2000). 
As secretory cells, ameloblasts may be particularly sensitive to 
induction of ER stress. Recently, the predominant secreted pro-
tein amelogenin has been found to bind to calnexin (a type I 
integral ER membrane chaperone that facilitates protein fold-
ing) in a yeast two-hybrid assay (Wang et al., 2005).
ACTIONS ON BONE AND BONE CELLS
Fluoride’s actions on bone appear to be mediated at several levels. 
Fluoride can directly interact with the bone mineral matrix physi-
cochemically (Grynpas, 1990; Grynpas and Rey, 1992; Pak et al., 
1995; Chachra et al., 1999). In vitro fluoridation of bone with mM 
[F] can lead to conversion of carbonated hydroxylapatite to 
carbonated fluorapatite, to changes in crystallinity, and to a reduc-
tion in mechanical strength properties (Silva and Ulrich, 2000; 
Freeman et al., 2001; DePaula et al., 2002). Fluorapatite is more 
stable and resistant to acid dissolution than is hydroxyapatite 
(Grynpas and Cheng, 1988). Fluoride also delays mineralization 
and is capable of altering bone crystal structure (Grynpas, 1990; 
Grynpas and Rey, 1992; Mousny et al., 2008).
In addition to physicochemical actions, fluoride at 10−5 M 
and 10−7 M can influence matrix metalloproteinases (MMPs), 
affecting the composition of the remodeling matrix and subse-
quent mineralization in a rat in vitro mineralizing bone cell 
culture (Waddington and Langley, 2003).
Fluoride can act on osteoblasts and osteoclasts in vivo and
in vitro. NaF is an anabolic agent capable of increasing bone 
mass, although the mechanism for its action remains unclear 
(Farley et al., 1983; Hall, 1987; Aaron et al., 1991; Lau and 
Baylink, 1998). While NaF may increase bone mass, the newly 
formed bone appears to lack normal structure and strength 
(Carter and Beaupre, 1990; Riggs et al., 1990; Søgaard et al., 
1994). In trabecular bone, fluoride results in an increase in bone 
volume and trabecular thickness without a concomitant increase 
in trabecular connectivity (Aaron et al., 1991). It is this lack of 
trabecular connectivity that reduces bone quality despite the 
increase in bone mass. These observations in humans have been 
extended in rodents (Søgaard et al., 1995; Turner et al., 1995). 
At low local concentrations such as those that occur following 
fluoride modification of dental implants, there is enhanced 
osteoblastic differentiation and interfacial bone formation con-
comitant with increased expression of osteogenic markers at the 
implant site (Cooper et al., 2006; Monjo et al., 2008). When 
fluoride-substituted apatite is implanted in vivo, there is an 
increase in new bone formation when the percentage of fluoride 
is low (0.5% by weight); however, when the percentage fluoride 
is higher (2.23% by weight), the enhanced new bone formation 
is abrogated (Inoue et al., 2005). High systemic fluoride expo-
sures can lead to skeletal fluorosis, a condition hallmarked by 
osteosclerosis, ligament calcifications, and often accompanying 
osteoporosis, osteomalacia, or osteopenia (Christie, 1980; Wang 
et al., 2007). Skeletal fluorosis can be complicated by malnutri-
tion (Teotia and Teotia, 2008).
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Fluoride can inhibit the function of isolated osteoclasts at 
modest [F] 0.5- to 1.0-mM (Okuda et al., 1990) or near-physiologic 
[F] 15-mg/L (approximately 0.8 mM) concentrations (Taylor 
et al., 1989) when examined in vitro. At a range of NaF from 
0.15 mg/L to 30 mg/L (approximately 0.004 mM to 0.7 mM), 
biphasic effects of fluoride have been described, depending 
upon concentration in the culture media (Taylor et al., 1990). At 
15-30 mg/L, osteoclast-resorptive activity was inhibited. 
However, at 1 mg/L (approximately 0.050 mM), osteoclast 
function was enhanced. The authors were unable to determine if 
the enhanced osteoclast function at 1 mg/L was a direct effect or 
indirect via an action on residual osteoblasts present in the cul-
ture system. Systemic fluoride treatment (50 ppm F ion in the 
drinking water over a period of 3 wks) results in the induction 
of osteoclastogenesis in the C3H/HeJ (C3H) inbred mouse 
strain, as evidenced by an increased number of osteoclasts along 
the trabecular bone surface in the tibiae (D Yan et al., 2007).
ACTIONS ON AMELOBLASTS
Dental fluorosis (DF) is an undesirable developmental defect of 
tooth enamel attributed to greater-than-optimal systemic fluo-
ride exposure during critical periods of amelogenesis. DF is 
characterized by increased porosity (subsurface hypomineral-
ization) with a loss of enamel translucency and increased opac-
ity (Fejerskov et al., 1990). It is generally accepted that 
increasing DF severity correlates with increasing F exposure; 
however, individual variation in DF severity can exist when F 
exposure is relatively constant in a community (Mabelya et al., 
1994; Yoder et al., 1998). Ameloblasts in the maturational phase 
appear to be the cellular target of chronic fluoride exposure 
(DenBesten and Thariani, 1992), whereas acute fluoride toxicity 
targets the transitional and early-secretory ameloblasts (Lyaruu 
et al., 2006). The mechanism(s) underlying DF remain obscure, 
but likely contribute to the observed retention of enamel matrix 
proteins and may include reduced removal of enamel matrix 
proteins during enamel maturation, perturbation of extracellular 
transport, or initiation of the ER stress-response pathway 
(Matsuo et al., 2000; DenBesten et al., 2002; Kubota et al., 
2005; Sharma et al., 2008; Bronckers et al., 2009; Everett et al., 
2009). While biological factors likely play critical roles in the 
pathogenesis of DF, physicochemical affects should also be 
considered (Robinson et al., 2004).
EFFECTS ON HEMATOPOIETIC CELLS  
AND HEMATOPOIESIS
Fluoride’s effects on hematopoietic cells/hematopoiesis have 
been investigated in ex vivo and in vitro studies and in different 
species of mammals. Effects vary depending upon fluoride dose, 
duration of exposure, and species, and include anemia and leu-
kopenia (Mehdi et al., 1978; Eren et al., 2005). At modest
in vitro concentrations (< 500 μM), NaF has been shown to 
promote the differentiation of human promyelocytic tumor cells 
(HL-60) to granulocyte-like cells (Kawase et al., 1996). Similar 
exposures of NaF (< 500 μM) can preferentially induce differ-
entiation of primary outbred ddY mouse bone marrow cells 
along the granulocytic pathway in vitro (Oguro et al., 2003). 
These latter studies confirmed differentiation of mouse bone 
marrow cells along the granulocytic lineage by demonstrating 
the up-regulation of granulocyte-specific markers (chloroacetate 
esterase, cell-surface antigens [Mac-1, Gr-1]) with no change in 
the monocyte-specific markers (non-specific esterase, cell- 
surface antigens [F4/80, MOMA-2]). The authors hypothesized 
that any potential shift in differentiation of bone marrow pro-
genitor cells away from the monocytic lineage may affect osteo-
clast formation.
Evidence that fluoride can affect the bone marrow microen-
vironment comes from ex vivo studies of bone marrow cells 
collected from several strains of mice treated with NaF in the 
drinking water. Strain-dependent effects on hematopoietic 
colony-forming cell unit (CFU) assays were observed (D Yan 
et al., 2007; Chou et al., 2009). Bone marrow cells leading to the 
individual colonies (CFU) may have pluripotent characteristics 
capable of giving rise to mixed colonies containing multiple 
hematopoietic lineages (e.g., granulocytic, monocytic, and ery-
throid) or are committed, giving rise to cells from one hemato-
poietic lineage.
Fluoride treatment of C3H mice shifted hematopoietic 
differentiation along the monocyte/macrophage lineage, with dose-
dependent increases in the frequencies of CFU-GEMM (colony-
forming unit granulocyte, erythroid, monocyte/macrophage, and 
megakaryocyte), CFU-GM (colony-forming unit granulocyte 
and monocyte/macrophage), and CFU-M (colony-forming unit 
monocyte/macrophage) colonies. Fluoride’s actions on the 
hematopoietic compartment in the B6 mouse strain differed with 
a modest increase in the frequency of pluripotential/mixed 
CFU-GEMM colonies at the highest F dose (100 ppm). The shift 
in hematopoietic differentiation in the C3H strain correlates 
with the increase in osteoclast potential observed (D Yan et al., 
2007). Important precursors for osteoclasts are the CFU-GM 
and CFU-M.
Mice from the C3H, C57BL/6J (B6), FVB/NJ (FVB), and 
BALB/cByJ (BALB) strains show strain-specific responses to 
fluoride in the frequencies CFU-F (colony-forming unit fibro-
blast) and CFU-OB/Alp+ (colony-forming unit osteoblast/alka-
line phosphatase positive) derived from bone marrow cells 
(Chou et al., 2009). The CFU-F are expanded clonal populations 
that emerge from single bone marrow stromal cells/mesenchy-
mal stem cells (MSC) and possess the potential to differentiate 
along multiple mesenchymal cell lineages, including osteoblast 
precursors (Friedenstein et al., 1976; Owen and Friedenstein, 
1988).
GENETIC STuDIES AND FLuORIDE’S ACTIONS
Until recently, few studies have explored the underlying genetic 
basis for fluoride resistance or susceptibility. Among the first, 
high concentrations of fluoride (400 μg/mL) have been used to 
isolate fluoride-resistant mutants of Caenorhabditis elegans 
(Katsura, 1993). Genetic studies of these mutant nematodes 
have led to the identification of novel fluoride-resistant (flr) 
genes, flr1, flr3, and flr4. The flr1 gene encodes an ion channel 
belonging to the degenerin/epithelial sodium channel superfam-
ily, which regulates defecation rhythm (Katsura et al., 1994; 
Take-Uchi et al., 1998). The flr4 gene encodes a predicted 
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Ser/Thr protein kinase and, like 
flr-1, appears to control rhythmic 
activities in Caenorhabditis ele-
gans (Iwasaki et al., 1995; Iwasaki 
and Thomas, 1997). The flr-4 gene 
is closely related to the human 
SOK1 gene, a Ste20 protein kinase 
of the germinal center kinase 
(GCK) family. The flr-3 gene 
remains to be characterized.
Dental Fluorosis Studies 
Involving Inbred 
Strains of Mice
Genetic studies utilizing inbred 
strains of mice have focused on 
fluoride’s action on tooth enamel 
development and bone homeosta-
sis (Everett et al., 2002, 2009; 
Vieira et al., 2005; Mousny et al., 2006, 2008; D Yan et al., 
2007; Carvalho et al., 2009; Chou et al., 2009). Inbred mouse 
strains have been used for genetic studies because of the isoge-
nicity within a strain and the genetic heterogeneity between 
inbred strains. The genetic diversity existing between inbred 
strains of mice has yielded phenotypes relevant to human health, 
such as cancer susceptibility, aging, obesity, susceptibility to 
infectious diseases, atherosclerosis, blood disorders, and neuro-
sensory disorders (Bogue and Grubb, 2004; Bogue et al., 2007; 
Grubb et al., 2009). Humans and mice differ in their dental for-
mulae, and mouse incisors continuously erupt. Despite these 
differences, mice have been instrumental in our understanding 
of the important cellular, molecular, and genetic processes con-
trolling odontogenesis. In addition to the genetic diversity 
between inbred strains of mice, the continuously erupting inci-
sors (active amelogenesis) facilitate the investigation of fluo-
ride’s effects on tooth enamel development at any time during 
the animal’s life. Strain-dependent responses to fluoride in the 
development of dental fluorosis were first demonstrated across 
12 inbred strains and the severity of dental fluorosis based upon 
clinical criteria (tooth enamel appearance) (Everett et al., 2002). 
Genetic diversity and availability were factors in the selection of 
these 12 strains. From that study, strains clustered into three 
dental fluorosis groups: resistant strains (129P3/J, FVB/NJ, 
CBA/J, and DBA/1J); intermediate strains (SWR/J, BALB/
cByJ, C57BL/10J, and DBA/2J); and sensitive strains (A/J, 
SJL/J/ C3H/HeJ, and C57BL/6J). Examples of the variation in 
dental fluorosis severity are illustrated in Fig. 1. As in humans 
with DF, clinical criteria can be used to score DF in mice. Since 
mouse incisors are worn away as they erupt, the DF observed 
does not reach the deeply pitted and characteristic brown stain-
ing seen with severe DF in humans. A modified Thylstrup and 
Fejerskov (TF) scale can be used to score dental fluorosis in 
mice (Everett et al., 2002, 2009). Alternatively, a modification 
of quantitative light-induced fluorescence (QLF) (Everett et al., 
2002; Vieira et al., 2005) can be used to provide a more objec-
tive means to score dental fluorosis (Fig. 2). Strains (129P3/J, 
SWR/J, and A/J) representing the three dental fluorosis groups 
described above were used to show that genetic factors (DF 
severity) and the environmental factor (fluoride concentration in 
tooth structure) have similar influence on tooth biomechanical 
properties, whereas only the environmental factor has an influ-
ence on tooth material properties (mineralization) (Vieira et al., 
2005). Fluoride metabolism also differs between and among 
mouse strains (Carvalho et al., 2009). Whereas the A/J strain 
consumes more drinking water and required adjustment in [F] to 
maintain comparable exposure between the two strains, the 
129P3/J strain retains more fluoride in the bone and has higher 
plasma fluoride levels. Despite this important difference, the 
129P3/J strain remains resistant to the development of dental 
fluorosis.
Resistance and susceptibility (risk factors), defined by host 
and environment interactions, as well as many quantitative phe-
notypes are considered complex traits. Complex traits (pheno-
types) can be assessed quantitatively and are under the control 
of multiple genes as well as non-genetic (environmental) fac-
tors. Multiple genes that contribute to the variation in a pheno-
typic trait are called quantitative trait loci (QTL). QTLs can be 
mapped in mice by traditional genetic approaches. Typically, 
two strains are selected that have widely different traits or 
responses. The parental mice are then used in a two-generation 
cross. First F1 hybrid progeny are generated, then used in sister-
brother mating to produce F2 mice (Fig. 3). While all F1 mice 
are genetically identical, each F2 mouse is unique. This is the 
result of re-arrangement of the parental alleles during gameto-
genesis (meiotic recombination) in the F1 animals. Mapping 
of QTLs associated with DF susceptibility was performed with 
a dental-fluorosis-resistant strain (129P3/J) and the dental- 
fluorosis-sensitive (A/J) strain in a two-generation cross to cre-
ate a panel of F2 mice as described above. All F2 mice were 
treated with fluoride 50 ppm F in the drinking water and, after 
60 days, were phenotyped for DF according to the modified TF 
scale. Treatment of F2 mice with 50 ppm F in the water yields a 
mean serum [F] of 12.366 ± 1.713 μM. The serum [F] concen-
trations between F2 mice with different DF severities were not 
significantly different and were not significantly different from 
Figure 1. Variation in dental fluorosis severity among inbred strains of mice. Mice at 5 to 6 wks of age 
were treated with fluoride (0 ppm or 50 ppm [F] ion) in the drinking water for 60 days. All strains 
developed dental fluorosis. Dental-fluorosis-susceptible strains are on the right, with those more resistant 
strains on the left side of the panel.
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serum [F] concentrations determined in comparably treated 
parental mice (11.296 ± 3.984 μM). To maximize the power to 
detect QTLs contributing to the variation in response to dental 
fluorosis, only the phenotypic extreme F2 animals (those with 
TF scores of 1 or 4) were genotyped for 354 SNP-based markers 
distributed throughout the mouse genome. This panel of 
mice was composed of equal numbers of males and females. 
Chi-square analysis was performed to compare the genotypic 
distributions in the two groups of phenotypically extreme F2 
mice. Significant evidence of association was observed on chro-
mosomes 2 and 11 for a series of consecutive markers (p < 
0.0001) (Everett et al., 2009). More importantly, there was a 
lack of significant association on murine chromosomes X, 3, 5, 
7, or 9, suggesting little role for amelogenin, ameloblastin, 
enamelin, amelotin, Klk-4, or Mmp20 in dental fluorosis 
susceptibility/resistance in this animal model. As illustrated above, 
the detection and mapping of QTL are straightforward in mice.
Narrowing the QTL intervals to fewer genes and, ultimately, 
the selection of candidate genes remain the challenging aspects 
of complex trait dissection. This can be accomplished in mice by 
increasing marker densities within QTLs and using a comple-
mentary approach based upon haplotype mapping. Haplotype 
Association Mapping (HAM) is a phenotype-driven approach to 
identify genetic loci in mice. This method is similar to Genome-
Wide Association Studies (GWAS) in humans. HAM looks for 
associations between the phenotype and the haplotypes of 
mouse inbred strains, treating inbred strains as individuals. 
Since mice within the strain are isogenic, several individuals can 
be phenotyped to minimize intra-strain variation. The applica-
tion of haplotype association mapping in mice was first described 
in 2001 and has developed into a useful tool for QTL mapping 
(Grupe et al., 2001; Tsaih and Korstanje, 2009). Integrating 
haplotype-based approaches with traditional mapping tools as 
described above has great potential for narrowing QTL mapping 
intervals and prioritizing candidate genes (Pletcher and 
Wiltshire, 2004; Cervino et al., 2005, 2007; Arbilly et al., 2006). 
It is conceivable that interval-specific haplotype analysis based 
upon an a priori knowledge of a QTL interval can reach a reso-
lution of less than 5 Mb (DiPetrillo et al., 2005). Recently, 
haplotype association mapping in mice identified a haplotype 
block containing the Cer1 (cerberus 1 homolog) gene that parti-
tions inbred mice strains into high and low bone mineral density 
groups. The Cer1 gene is important during embryonic develop-
ment and appears to play a role in bone development. Based 
upon the discovery in mice, the human CER1 gene was investi-
gated, and a non-synonymous SNP (rs3747532) was identified 
to be associated with increased risk of low bone mineral density 
in pre-menopausal women (Tang et al., 2009).
QTL linkage studies in mice differ from QTL mapping in 
humans because many human QTL linkage studies are limited 
in sample size and do not have the family pedigrees that maxi-
mize the power to detect linkage (Almasy and Blangero, 2009). 
High-throughput genotyping and advanced computational anal-
yses have led to the application of genome-wide association 
studies (GWAS) as a tool for mapping human disease genes 
(Hindorff et al., 2009). As of December 2009, there have been 
658 published genome-wide association studies in humans 
(Hindorff et al., 2010).
Bone and Bone Biology Studies Involving  
Inbred Strains of Mice
Strain-specific responses to fluoride also include effects on bone 
mineral, bone micro-architecture, and bone cell biology. Bone 
quality as a function of mechanical properties varies among 
Figure 2. Use of quantitative fluorescence to assess dental fluorosis. 
Panels A and C are clinical images of the mandibular incisors from A/J 
mice treated with control (0 ppm [F]), Panel A; and 50 ppm [F], Panel 
C) for 60 days. Panels B and D demonstrate the results of quantitative 
fluorescence (QF), where a Nikon epifluorescence microscope 
equipped with a Chroma Gold 11006v2 set cube (Spectra Services 
Inc., Ontario, NY, USA) (exciter D360/40x, dichroic 400DCLP, and 
emitter E515LPv2) was used to assess the severity of dental fluorosis. 
Increased fluorescence is associated with increased dental fluorosis 
severity.
Figure 3. Schematic using inbred progenitor strains in a two-generation 
cross to produce a panel of F2 progeny. P1 and P2 are progenitor/
parental strains that differ in a particular trait of response. The F1 
progeny (1st generation) are all genetically identical, having inherited 
half their genome from P1 and half their genome from P2. The F2 
progeny (2nd generation) are composed of genetically unique 
individuals.
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three inbred strains (A/J, SWR/J, and 129P3/J) following fluo-
ride exposure (Mousny et al., 2006). The A/J strain demon-
strated the greatest reduction in bone quality in a fluoride 
dose-dependent manner. The SWR/J strain demonstrated a mod-
est reduction in bone quality, and the 129P3/J strain was refrac-
tory to the effects of fluoride. In an effort to better understand 
the changes in bone quality observed above, investigators 
assessed the effects of fluoride on bone formation and mineral-
ization (Mousny et al., 2008). All three strains demonstrated an 
increase in osteoid with the vertebral bodies, which did not 
translate to increases in bone volume of mineralization.
Mice representing the C3H and B6 inbred strains have been 
particularly useful in studies of bone biology. In a landmark 
paper, Beamer and co-workers (1996) investigated peak bone 
mass in a variety of inbred strains of mice, and with respect to 
strain differences, the highest value for any given bone param-
eter was found in the C3H strain, whereas B6 values were abso-
lutely, or statistically, the lowest. These two strains have become 
the foundation for many investigations contributing to more 
than 76 scientific articles in the literature, with the majority 
resulting from studies of bone cells and bone biology. As genetic 
tools, B6 and C3H mice have contributed to the identification of 
several quantitative trait loci (QTLs) implicated in determining 
peak bone mass (Beamer et al., 2001; Koller et al., 2003; 
Bouxsein et al., 2004). This formed the basis for the selection of 
C3H and B6 strains for studies involving fluoride. Exposure to 
fluoride at levels relevant to what might be experienced in 
humans (Srivastava et al., 1989; Riggs et al., 1990) was 
achieved by treatment of mice with NaF for 3 wks, achieving 
mean serum [F] of 8 μM (50 ppm F in the water) or 15 μM (100 
ppm F in the water).
As discussed above, fluoride can have effects on the bone 
marrow microenvironment. The bone marrow provides a source 
for osteoprogenitors as well as osteoclast precursors. In addition 
to the increased osteoclast potential in C3H mice following 
fluoride treatment, there are concurrent changes in markers for 
markers of osteoclast activity in vivo (D Yan et al., 2007). 
Fluoride induces intact parathyroid hormone (iPTH), soluble 
receptor activator for nuclear factor kappa B ligand (RANKL), 
and osteoclast-specific tartrate-resistant acid phosphatase 
(Trap5b) in the serum of C3H mice. PTH conveys effects on 
osteoblast cells, which in turn produce factors like RANKL. 
PTH is an important early step in osteoclastogenesis. It is also 
worth noting that there have been repeated associations between 
increased fluoride intake and increases in circulating PTH and 
hyperparathyroidism (Sivakumar and Krishnamachari, 1976; 
Ream and Principato, 1981; Gupta et al., 2001; Chadha and 
Kumar, 2004). Stronger evidence of enhanced osteoclastogene-
sis is the increase in the number of osteoclasts along the bone 
surfaces in C3H mice. B6 mice respond quite oppositely (D Yan 
et al., 2007). In this strain, the anabolic actions of fluoride are 
favored. There is an increase in total alkaline phosphatase 
(ALP) in the serum, with a concomitant decrease in the pro-
osteoclastogenesis markers iPTH and RANKL. Finally, there is 
a modest increase in trabecular bone BMD and reduction in 
bone quality in B6 mice. A summary of the differential actions 
of fluoride on B6 and C3H mice is shown in Fig. 4.
As mentioned earlier, C3H and B6 mice differ in their peak 
bone mass. Many other notable differences in bone and bone 
biology exist between these two strains. In particular, bone 
adaptation responses in B6 mice are greater than those in C3H 
(Akhter et al., 1998, 2002; Amblard et al., 2003), and bone loss 
due to disuse is also greater in B6 mice (Judex et al., 2004). C3H 
mice operate at a high-bone-mass production mode, where per-
haps the anabolic actions of fluoride are not favored as in B6 
mice. Mapping studies similar to that undertaken to identify 
DF-associated QTLs can be undertaken with B6 and C3H mice 
as progenitor strains to identify QTLs associated with fluoride’s 
actions on osteoclastogenesis.
SuMMARY
Fluoride in various chemical forms, doses, and exposures has 
physicochemical and biologic effects on cells and tissues. A 
narrow therapeutic/toxicity window and biphasic actions fur-
ther complicate our understanding of fluoride’s effects. 
Fluorides mediate their actions through MAPK signaling path-
ways, leading to changes in gene expression, cell stress, and 
even cell death. Fluorides can lead to a diverse collection of 
responses affecting biomineralization. The role that an indi-
vidual’s genetic background plays in modulating fluoride’s 
actions is becoming more evident and will allow for the inves-
tigation of gene-gene and gene-environment interactions capa-
ble of modifying the function(s) of fluoride-responsive genetic 
variants in an animal model. This in turn will provide a better 
understanding of the effects of fluoride on human bone, bone 
cells, and tooth enamel development. Future studies will likely 
focus on identifying and characterizing fluoride-responsive 
genetic variations (e.g., polymorphisms), and on identifying 
those at-risk human populations who are susceptible to the 
unwanted or potentially adverse effects of fluoride action, and, 
finally, on elucidation of the fundamental mechanisms by 
which fluoride affects biomineralization.
Figure 4. Dichotomy of fluoride responses between the high-bone-mass 
C3H/HeJ and low-bone-mass C57BL/6J inbred strains. The C57BL/6J 
strain favors the anabolic actions of fluoride, whereas the C3H/HeJ 
strain demonstrates enhanced osteoclastogenesis.
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